■负重计算机断层扫描(WBCT)正在成为评估足部和踝关节病理学的有价值的工具。目前,文献中缺乏对私人诊所中WBCT扫描仪的成本分析。这项研究评估了收购成本,利用率,以及在三级转诊中心进行WBCT的报销,考虑获得此类设备的实践特别感兴趣的信息。
在55个月期间(2016年8月至2021年2月)在三级转诊中心进行的所有WBCT扫描均进行了回顾性评估。患者人口统计学,病理位置,病因学,订购提供商的子专业,并收集研究是单边的还是双边的.报销是根据付款人来源计算的,占下肢CT医疗保险报销的百分比。评估每月执行的总扫描次数以确定每月产生的收入。
■在研究期间,1903年进行扫描。平均每个月进行34.6次扫描。41个提供者在研究期间订购了WBCT扫描。接受过足踝部奖学金培训的整形外科医生订购了所有扫描的75.5%。最常见的病理部位是脚踝,最常见的病因是外伤.该设备在44.2个月时成本中性,假设每项研究的报销与Medicare费率相称.根据混合付款人来源计算报销时,该设备在大约29.9个月时变得成本中性。
■随着WBCT扫描越来越广泛地用于评估足部和踝关节的病理,实践可能有兴趣了解这种投资的财务影响。就作者所知,本研究是美国唯一的WBCT成本效益分析。我们发现在一个大的,多专业骨科组,WBCT可以是财务上可行的资产,也是各种病理的有价值的诊断工具。
■三级,诊断。
UNASSIGNED: Weightbearing computed tomography (WBCT) is becoming a valuable tool in the evaluation of foot and ankle pathology. Currently, cost analyses of WBCT scanners in private practice are lacking in the literature. This study evaluated the costs of acquisition, utilization, and reimbursements for a WBCT at a tertiary referral center, information of particular interest to practices considering obtaining such equipment.
UNASSIGNED: All WBCT scans performed at a tertiary referral center over the 55-month period (August 2016 to February 2021) were retrospectively evaluated. Patient demographics, pathology location, etiology, subspecialty of the ordering provider, and whether the study was unilateral or bilateral were collected. Reimbursement was calculated based on payor source as a percentage of Medicare reimbursement for lower extremity CT. The number of total scans performed per month was evaluated to determine revenue generated per month.
UNASSIGNED: Over the study period, 1903 scans were performed. An average of 34.6 scans were performed each month. Forty-one providers ordered WBCT scans over the study period. Foot and ankle fellowship-trained orthopaedic surgeons ordered 75.5% of all scans. The most common location of pathology was the ankle, and the most common etiology was trauma. The device was cost neutral at 44.2 months, assuming reimbursement for each study was commensurate with Medicare rates. The device became cost neutral at approximately 29.9 months when calculating reimbursement according to mixed-payor source.
UNASSIGNED: As WBCT scan becomes more widely used for evaluation of foot and ankle pathology, practices may be interested in understanding the financial implications of such an investment. To the authors\' knowledge, this study is the only cost-effectiveness analysis of WBCT based in the United States. We found that in a large, multispecialty orthopaedic group, WBCT can be a financially viable asset and a valuable diagnostic tool for a variety of pathologies.
UNASSIGNED: Level III, diagnostic.